Literature DB >> 26700394

Implementation of the Lancet Standing Commission on Liver Disease in the UK.

Roger Williams1, Kathryn Ashton2, Richard Aspinall3, Mark A Bellis4, Joanne Bosanquet5, Matthew E Cramp6, Natalie Day7, Anil Dhawan8, John Dillon9, Jessica Dyson10, James Ferguson11, Graham Foster12, Sir Ian Gilmore13, Michael Glynn14, J Ashley Guthrie15, Mark Hudson16, Deirdre Kelly17, Andrew Langford18, Philip Newsome19, John O'Grady8, Rachel Pryke20, Stephen Ryder21, Marianne Samyn8, Nick Sheron22, Julia Verne5.   

Abstract

Mesh:

Year:  2015        PMID: 26700394     DOI: 10.1016/S0140-6736(15)00680-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  The growing burden of liver cirrhosis: implications for preventive measures.

Authors:  Martin C S Wong; Junjie Huang
Journal:  Hepatol Int       Date:  2018-04-20       Impact factor: 6.047

2.  Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost.

Authors:  Wai Hoong Chang; Stefanie H Mueller; Sheng-Chia Chung; Graham R Foster; Alvina G Lai
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

3.  Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study.

Authors:  Arulraj Ramakrishnan; Ganesan Velmurugan; Aravindh Somasundaram; Sundaresan Mohanraj; Dinakaran Vasudevan; Paari Vijayaragavan; Peter Nightingale; Krishnan Swaminathan; James Neuberger
Journal:  EClinicalMedicine       Date:  2022-07-14

4.  The Immunological Effect of Oxygen Carriers on Normothermic Ex Vivo Liver Perfusion.

Authors:  Heather Jennings; Kristin N Carlson; Chris Little; Joshua C Verhagen; Jeevan Nagendran; Yongjun Liu; Bret Verhoven; Weifeng Zeng; Stacey McMorrow; Peter Chlebeck; David P Al-Adra
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

5.  The Use of an Acellular Oxygen Carrier in a Human Liver Model of Normothermic Machine Perfusion.

Authors:  Richard W Laing; Ricky H Bhogal; Lorraine Wallace; Yuri Boteon; Desley A H Neil; Amanda Smith; Barney T F Stephenson; Andrea Schlegel; Stefan G Hübscher; Darius F Mirza; Simon C Afford; Hynek Mergental
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

6.  The pathway to better primary care for chronic liver disease.

Authors:  Helen Jarvis; Stuart McPherson; Quentin M Anstee; Barbara Hanratty
Journal:  Br J Gen Pract       Date:  2021-03-26       Impact factor: 5.386

Review 7.  Targeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise Literature.

Authors:  Kate Hallsworth; Leah Avery; Michael I Trenell
Journal:  Curr Gastroenterol Rep       Date:  2016-03

8.  Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial.

Authors:  Richard W Laing; Hynek Mergental; Christina Yap; Amanda Kirkham; Manpreet Whilku; Darren Barton; Stuart Curbishley; Yuri L Boteon; Desley A Neil; Stefan G Hübscher; M Thamara P R Perera; Paolo Muiesan; John Isaac; Keith J Roberts; Hentie Cilliers; Simon C Afford; Darius F Mirza
Journal:  BMJ Open       Date:  2017-11-28       Impact factor: 2.692

9.  Guidelines on the management of abnormal liver blood tests.

Authors:  Philip N Newsome; Rob Cramb; Suzanne M Davison; John F Dillon; Mark Foulerton; Edmund M Godfrey; Richard Hall; Ulrike Harrower; Mark Hudson; Andrew Langford; Anne Mackie; Robert Mitchell-Thain; Karen Sennett; Nicholas C Sheron; Julia Verne; Martine Walmsley; Andrew Yeoman
Journal:  Gut       Date:  2017-11-09       Impact factor: 23.059

10.  Interaction Between Alcohol Consumption and PNPLA3 Variant in the Prevalence of Hepatic Steatosis in the US Population.

Authors:  Mariana Lazo; Usama Bilal; Mack C Mitchell; James Potter; Ruben Hernaez; Jeanne M Clark
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-31       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.